For the Inventor, By the Inventor

Enter assignee name

Jerusalem, Israel

Hadasit Medical Research Services and Development Company

USPTO Granted Patents = 31

CIPO Patents = 3

EPO Patents = 5

Forward Citations = 272

Loading Chart...

Loading Chart...

63 inventors (with patents filed for the assignee):

Mark Pines (8 out of 14 patents)

Arnon Nagler (8 out of 14 patents)

Shimon Slavin (5 out of 24 patents)

4. Israel Vlodavsky (5 out of 33 patents)

5. Raphael Gorodetsky (3 out of 14 patents)

6. Rachel Bar-Shavit (3 out of 6 patents)

7. Yaakov Naparstek (2 out of 13 patents)

8. Eithan Galun (2 out of 10 patents)

9. Justin Silver (2 out of 2 patents)

10. Zeev Weshler (2 out of 3 patents)

11. Gerard Marx (2 out of 15 patents)

12. Raymond Kaempfer (1 out of 12 patents)

13. Neta Ilan (1 out of 3 patents)

14. Tony Peled (1 out of 22 patents)

15. Stefan Rose-John (1 out of 12 patents)

31 patents: Sort by Forward Citations

1. 9023859 - Composition and method for treating or preventing skeletal muscle fibrosis (2015-05-05),

2. 7772187 - Substances directed against a specific sequence essential for heparanase catalytic activity and uses thereof as heparanase inhibitors (2010-08-10),

3. 7771343 - System and method for treating chronic pain (2010-08-10),

4. 7544655 - Haptotactic peptides (2009-06-09),

5. RE39574 - Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies (2007-04-16),

6. 7148190 - Haptotactic peprides (2006-12-12),

7. RE39096 - Treatment of skin disorders (2006-05-15),

8. 6410009 - Pharmaceutical composition for treating hepatitis B virus (HBV) infection (2002-06-25),

9. 6395496 - Method and kit for evaluating the metastatic tendency of tumors (2002-05-28),

10. 6372262 - Serum-derived factor inducing cell differentiation and medical uses thereof (2002-04-16),

11. 6303155 - Treatment of conditions associated with impairment in the level of the parathyroid hormone (2001-10-16),

12. 6228363 - Peptides for the treatment of systemic lupus erythematosus (2001-05-08),

13. 6211188 - Treatment of skin disorders (2001-04-03),

14. 6190302 - Stereotactic radiotreatment and prevention of restenosis (2001-02-20),

15. 6183954 - Method for evaluating the metastatic tendency of tumors (2001-02-06),

Hadasit Medical Research Services and Development Company is a leading Israeli technology transfer company dedicated to commercializing innovative medical technologies. We collaborate with Hadassah Medical Center, one of the largest and most advanced hospitals in Israel, to transform cutting-edge research into practical applications and healthcare solutions. Our diverse portfolio includes technologies in biotechnology, diagnostics, therapeutics, medical devices, and digital health. With a team of experts in business development, intellectual property, and licensing, we support the commercialization efforts of our inventors and promote partnerships with industry leaders worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

31 Patents

#8 in Jerusalem

#169 in Israel

#20,604 in the World

Jerusalem, Israel

Hadasit Medical Research Services and Development Company

Forward Citations = 272

63 inventors:

Mark Pines (8 out of 14 patents)

Arnon Nagler (8 out of 14 patents)

Shimon Slavin (5 out of 24 patents)

4. Israel Vlodavsky (5 out of 33 patents)

5. Raphael Gorodetsky (3 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…